A double-blind placebo controlled trial of modafinil for negative symptoms in schizophrenia

被引:0
作者
Pierre, J [1 ]
Peloian, JH [1 ]
Wirshing, DA [1 ]
Wirshing, WC [1 ]
Marder, SR [1 ]
机构
[1] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Geffen Sch Med, Los Angeles, CA 90024 USA
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:501 / 501
页数:1
相关论文
共 50 条
[41]   CLONAZEPAM TREATMENT OF CHRONIC-SCHIZOPHRENIA - NEGATIVE RESULTS IN A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
KARSON, CN ;
WEINBERGER, DR ;
BIGELOW, L ;
WYATT, RJ .
AMERICAN JOURNAL OF PSYCHIATRY, 1982, 139 (12) :1627-1628
[42]   Improvement of schizophrenia negative and positive symptoms with memantine as add-on therapy to clozapine: a double-blind, randomized, placebo-controlled trial [J].
Lucena, D. ;
Fernandes, B. ;
Berk, M. ;
Dodd, S. ;
Medeiros, D. W. ;
Pedrini, M. ;
Kunz, M. ;
Gomes, F. ;
Giglio, L. ;
Lobato, M. I. ;
Belmonte-de-Abreu, P. ;
Gama, C. S. .
BIPOLAR DISORDERS, 2009, 11 :57-57
[43]   Improvement of Schizophrenia Negative and Positive Symptoms With Memantine as Add-On Therapy to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial [J].
de Lucena, David ;
Fernandes, Brisa ;
Berk, Michael ;
Dood, Seetal ;
Medeiros, Dalton W. ;
Pedrini, Mariana ;
Kunz, Mauricio ;
Gomes, Fabiano ;
Giglio, Larriany ;
Lobato, Maria Ines ;
Belmonte-de-Abreu, Paulo ;
Gama, Clarissa S. .
BIOLOGICAL PSYCHIATRY, 2009, 65 (08) :211S-211S
[44]   A 10-WEEK, DOUBLE-BLIND, PLACEBO CONTROLLED, CROSS-OVER TRIAL OF ADJUNCTIVE MODAFINIL FOR NEUROCOGNITIVE IMPAIRMENTS IN SCHIZOPHRENIA [J].
Letourneau, Karine ;
Demers, M. F. ;
Simard, M. ;
Emond, C. ;
Roy, M. A. .
SCHIZOPHRENIA BULLETIN, 2009, 35 :283-283
[45]   Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment [J].
Chaudhry, Imran B. ;
Hallak, Jaime ;
Husain, Nusrat ;
Minhas, Fareed ;
Stirling, John ;
Richardson, Paul ;
Dursun, Serdar ;
Dunn, Graham ;
Deakin, Bill .
JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (09) :1185-1193
[46]   RETRACTED: Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial (Retracted Article) [J].
Abdallah, Mahmoud S. ;
Mosalam, Esraa M. ;
Hassan, Ahmed ;
Ramadan, Ahmed N. ;
Omara-Reda, Hend ;
Zidan, Abdel-Aziz A. ;
Samman, Waad A. ;
El-Berri, Eman, I .
CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (01) :354-364
[47]   Minocycline benefits negative symptoms in early schizophrenia; A randomised double-blind placebo-controlled clinical trial in patients on a standard treatment [J].
Chaudhry, I. B. ;
Hallak, J. ;
Husain, N. ;
Laganis, C. ;
Minhas, F. ;
Stirling, J. ;
Richardson, P. ;
Dursun, S. ;
Dunn, G. ;
Deakin, J. F. W. .
EARLY INTERVENTION IN PSYCHIATRY, 2012, 6 :100-100
[48]   N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms [J].
Neill, Erica ;
Rossell, Susan L. ;
Yolland, Caitlin ;
Meyer, Denny ;
Galletly, Cherrie ;
Harris, Anthony ;
Siskind, Dan ;
Berk, Michael ;
Bozaoglu, Kiymet ;
Dark, Frances ;
Dean, Olivia M. ;
Francis, Paul S. ;
Liu, Dennis ;
Phillipou, Andrea ;
Sarris, Jerome ;
Castle, David J. .
SCHIZOPHRENIA BULLETIN, 2022, 48 (06) :1263-1272
[49]   Modafinil for treatment of daytime sleepiness in Parkinson's disease:: A double-blind placebo controlled trial [J].
Högl, B ;
Saletu, M ;
Glatzl, S ;
Frauscher, B ;
Brandauer, E ;
Poewe, W .
SLEEP, 2002, 25 :A256-A256
[50]   A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence [J].
Shearer, James ;
Darke, Shane ;
Rodgers, Craig ;
Slade, Tim ;
van Beek, Ingrid ;
Lewis, John ;
Brady, Donna ;
McKetin, Rebecca ;
Mattick, Richard P. ;
Wodak, Alex .
ADDICTION, 2009, 104 (02) :224-233